Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Fei Ma
CONTACT
Hongnan Mo
CONTACT
Lead
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A multicenter, single-arm study was conducted in 32 patients with HER2-positive breast cancer and 32 HER2-low expression patients to explore the efficacy and safety of RC48 in metastatic human epidermal growth factor receptor 2 (HER2) expressing breast cancer with abnormal activation of PAM pathway.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted